Psych · Consultation-liaison psychiatry
Psycho-oncology
Also known as Cancer psychiatry · Psychosocial oncology · Oncology consultation-liaison · Distress in cancer · Depression in cancer
Exam-exhaustive fellowship topic on psycho-oncology for consultation-liaison psychiatry — distress screening, adjustment and demoralisation, major depression and collaborative care (SMaRT Oncology), delirium in cancer and palliative settings, corticosteroid neuropsychiatry, capacity and end-of-life assessment, suicide risk after diagnosis, SSRI–tamoxifen CYP2D6 interactions, and psychological therapies including meaning-centred psychotherapy. FRANZCP-primary, globally tagged.
Practise this topic
On this page
Study tools
Your progress
Saved on this device.
Target exams
Red flags
- New confusion or fluctuating inattention in a cancer patient — treat as delirium until proven otherwise; do not start antidepressants alone
- Active suicidal ideation after a new or progressive cancer diagnosis — early post-diagnosis period is high risk
- Paroxetine or fluoxetine co-prescribed with tamoxifen — strong CYP2D6 inhibition may reduce endoxifen exposure
- High-dose corticosteroids with acute mania, psychosis, or severe insomnia — consider steroid neurotoxicity before a primary bipolar label
- Routine antipsychotics for palliative delirium without non-drug care — Agar RCT showed worse symptom scores than placebo
- Treatment refusal or major financial decisions while delirious, manic on steroids, or severely depressed without capacity assessment
- Uncontrolled pain, hypercalcaemia, hyponatraemia, brain metastases, or infection presenting as 'depression' or 'agitation'
Meet the patient
A 61-year-old woman six weeks into treatment for breast cancer is referred for "depression and anxiety". She is tearful, wakes at 4am, and tells you her family "would be better off without this version of me". She started tamoxifen a month ago, and her GP added paroxetine for sleep two weeks later.[5][13]
Three exam questions are now live in one referral, and the registrar will collapse them into "she's low, start an SSRI". Is this depression, adjustment, or demoralisation? Is she safe? And is paroxetine the right antidepressant on tamoxifen? Everything below is how you separate the syndromes, pick the right drug, and avoid the classic interaction that costs marks and harms patients.[5][6][13]
References25ShowHide
- [1]Mitchell AJ, Chan M, Bhatti H, et al. Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: a meta-analysis of 94 interview-based studies Lancet Oncol, 2011.PMID 21251875
- [2]Walker J, Hansen CH, Martin P, et al. Prevalence, associations, and adequacy of treatment of major depression in patients with cancer: a cross-sectional analysis of routinely collected clinical data Lancet Psychiatry, 2014.PMID 26360998
- [3]Sharpe M, Walker J, Holm Hansen C, et al. Integrated collaborative care for comorbid major depression in patients with cancer (SMaRT Oncology-2): a multicentre randomised controlled effectiveness trial Lancet, 2014.PMID 25175478
- [4]Walker J, Hansen CH, Martin P, et al. Integrated collaborative care for major depression comorbid with a poor prognosis cancer (SMaRT Oncology-3): a multicentre randomised controlled trial in patients with lung cancer Lancet Oncol, 2014.PMID 25175097
- [5]Kelly CM, Juurlink DN, Gomes T, et al. Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study BMJ, 2010.PMID 20142325
- [6]Agar MR, Lawlor PG, Quinn S, et al. Efficacy of Oral Risperidone, Haloperidol, or Placebo for Symptoms of Delirium Among Patients in Palliative Care: A Randomized Clinical Trial JAMA Intern Med, 2017.PMID 27918778
- [7]Fang F, Fall K, Mittleman MA, et al. Suicide and cardiovascular death after a cancer diagnosis N Engl J Med, 2012.PMID 22475594
- [8]Clarke DM, Kissane DW Demoralization: its phenomenology and importance Aust N Z J Psychiatry, 2002.PMID 12406115
- [9]Robinson S, Kissane DW, Brooker J, et al. A systematic review of the demoralization syndrome in individuals with progressive disease and cancer: a decade of research J Pain Symptom Manage, 2015.PMID 25131888
- [10]Holland JC Distress screening and the integration of psychosocial care into routine oncologic care J Natl Compr Canc Netw, 2013.PMID 23704244
- [11]Holland JC, Andersen B, Breitbart WS, et al. Distress management J Natl Compr Canc Netw, 2013.PMID 23411386
- [12]Warrington TP, Bostwick JM Psychiatric adverse effects of corticosteroids Mayo Clin Proc, 2006.PMID 17036562
- [13]Pitman A, Suleman S, Hyde N, et al. Depression and anxiety in patients with cancer BMJ, 2018.PMID 29695476
- [14]Ostuzzi G, Matcham F, Dauchy S, et al. Antidepressants for the treatment of depression in people with cancer Cochrane Database Syst Rev, 2018.PMID 29683474
- [15]Rayner L, Price A, Evans A, et al. Antidepressants for the treatment of depression in palliative care: systematic review and meta-analysis Palliat Med, 2011.PMID 20935027
- [16]Dubovsky AN, Arvikar S, Stern TA, et al. The neuropsychiatric complications of glucocorticoid use: steroid psychosis revisited Psychosomatics, 2012.PMID 22424158
- [17]Ismail MF, Lavelle C, Cassidy EM Steroid-induced mental disorders in cancer patients: a systematic review Future Oncol, 2017.PMID 29186986
- [18]Temel JS, Greer JA, Muzikansky A, et al. Early palliative care for patients with metastatic non-small-cell lung cancer N Engl J Med, 2010.PMID 20818875
- [19]Breitbart W, Rosenfeld B, Pessin H, et al. Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer J Clin Oncol, 2015.PMID 25646186
- [20]Breitbart W, Poppito S, Rosenfeld B, et al. Pilot randomized controlled trial of individual meaning-centered psychotherapy for patients with advanced cancer J Clin Oncol, 2012.PMID 22370330
- [21]Donovan KA, Grassi L, McGinty HL, et al. Validation of the distress thermometer worldwide: state of the science Psychooncology, 2014.PMID 25160838
- [22]Mulick A, Walker J, Puntis S, et al. Does depression treatment improve the survival of depressed patients with cancer? A long-term follow-up of participants in the SMaRT Oncology-2 and 3 trials Lancet Psychiatry, 2018.PMID 29544711
- [23]Inouye SK, van Dyck CH, Alessi CA, et al. Clarifying confusion: the confusion assessment method. A new method for detection of delirium Ann Intern Med, 1990.PMID 2240918
- [24]Mitchell AJ, Ferguson DW, Gill J, et al. Depression and anxiety in long-term cancer survivors compared with spouses and healthy controls: a systematic review and meta-analysis Lancet Oncol, 2013.PMID 23759376
- [25]Rayner L, Price A, Hotopf M, et al. The development of evidence-based European guidelines on the management of depression in palliative cancer care Eur J Cancer, 2011.PMID 21211961